Trinity Biotech EBITDA Margin 2012-2025 | TRIB
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Trinity Biotech (TRIB) over the last 10 years. The current EBITDA margin for Trinity Biotech as of September 30, 2025 is .
| Trinity Biotech EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.05B | $-0.02B | -40.82% |
| 2025-06-30 | $0.05B | $-0.02B | -44.00% |
| 2025-03-31 | $0.06B | $-0.02B | -41.82% |
| 2024-12-31 | $0.06B | $-0.02B | -30.65% |
| 2024-09-30 | $0.06B | $-0.01B | -18.64% |
| 2024-06-30 | $0.06B | $-0.01B | -22.03% |
| 2024-03-31 | $0.06B | $-0.02B | -40.35% |
| 2023-12-31 | $0.06B | $-0.02B | -42.11% |
| 2023-09-30 | $0.06B | $-0.03B | -46.67% |
| 2023-06-30 | $0.06B | $-0.03B | -50.82% |
| 2023-03-31 | $0.06B | $-0.02B | -30.65% |
| 2022-12-31 | $0.06B | $-0.02B | -26.98% |
| 2022-09-30 | $0.07B | $-0.01B | -13.43% |
| 2022-06-30 | $0.07B | $0.00B | 2.74% |
| 2022-03-31 | $0.08B | $0.00B | 4.76% |
| 2021-12-31 | $0.09B | $0.01B | 8.51% |
| 2021-09-30 | $0.11B | $0.00B | -3.74% |
| 2021-06-30 | $0.12B | $0.00B | 0.85% |
| 2021-03-31 | $0.11B | $0.00B | 1.87% |
| 2020-12-31 | $0.10B | $0.00B | 0.98% |
| 2020-09-30 | $0.09B | $-0.02B | -17.78% |
| 2020-06-30 | $0.08B | $-0.02B | -28.92% |
| 2020-03-31 | $0.09B | $-0.02B | -26.97% |
| 2019-12-31 | $0.09B | $-0.03B | -27.78% |
| 2019-09-30 | $0.09B | $-0.02B | -23.40% |
| 2019-06-30 | $0.09B | $-0.02B | -23.66% |
| 2019-03-31 | $0.10B | $-0.02B | -21.88% |
| 2018-12-31 | $0.10B | $-0.02B | -20.41% |
| 2018-09-30 | $0.10B | $-0.04B | -37.76% |
| 2018-06-30 | $0.10B | $-0.04B | -36.00% |
| 2018-03-31 | $0.10B | $-0.04B | -36.00% |
| 2017-12-31 | $0.10B | $-0.04B | -37.00% |
| 2017-09-30 | $0.10B | $-0.04B | -42.42% |
| 2017-06-30 | $0.10B | $-0.04B | -41.41% |
| 2017-03-31 | $0.10B | $-0.04B | -41.00% |
| 2016-12-31 | $0.10B | $-0.04B | -40.00% |
| 2016-09-30 | $0.10B | $0.01B | 9.90% |
| 2016-06-30 | $0.10B | $0.01B | 9.90% |
| 2016-03-31 | $0.10B | $0.01B | 11.11% |
| 2015-12-31 | $0.10B | $0.01B | 13.00% |
| 2015-09-30 | $0.10B | $0.01B | 10.78% |
| 2015-06-30 | $0.10B | $0.01B | 12.62% |
| 2015-03-31 | $0.11B | $0.02B | 14.29% |
| 2014-12-31 | $0.11B | $0.02B | 15.24% |
| 2014-09-30 | $0.10B | $0.02B | 14.56% |
| 2014-06-30 | $0.10B | $0.02B | 15.00% |
| 2014-03-31 | $0.10B | $0.01B | 14.74% |
| 2013-12-31 | $0.09B | $0.01B | 14.44% |
| 2013-09-30 | $0.09B | $0.02B | 23.26% |
| 2013-06-30 | $0.08B | $0.02B | 22.89% |
| 2013-03-31 | $0.08B | $0.02B | 22.89% |
| 2012-12-31 | $0.08B | $0.02B | 22.89% |
| 2012-09-30 | $0.08B | $0.02B | 23.17% |
| 2012-06-30 | $0.08B | $0.02B | 23.46% |
| 2012-03-31 | $0.08B | $0.02B | 24.05% |
| 2011-12-31 | $0.08B | $0.02B | 23.08% |
| 2011-09-30 | $0.08B | $0.01B | 18.18% |
| 2011-06-30 | $0.08B | $0.01B | 17.11% |
| 2011-03-31 | $0.08B | $0.01B | 16.25% |
| 2010-12-31 | $0.09B | $0.01B | 15.56% |
| 2010-09-30 | $0.10B | $0.01B | 13.73% |
| 2010-06-30 | $0.12B | $0.02B | 13.04% |
| 2010-03-31 | $0.12B | $0.02B | 12.10% |
| 2009-12-31 | $0.13B | $0.01B | 11.11% |
| 2009-09-30 | $0.13B | $-0.08B | -58.91% |
| 2009-06-30 | $0.13B | $-0.08B | -58.65% |
| 2009-03-31 | $0.14B | $-0.08B | -58.39% |
| 2008-12-31 | $0.14B | $-0.08B | -57.86% |
| 2008-09-30 | $0.14B | $0.04B | 29.58% |
| 2008-06-30 | $0.14B | $0.04B | 30.00% |
| 2008-03-31 | $0.14B | $0.04B | 31.21% |
| 2007-12-31 | $0.14B | $0.08B | 54.86% |
| 2007-09-30 | $0.14B | $0.08B | 53.90% |
| 2007-06-30 | $0.14B | $0.08B | 54.29% |
| 2007-03-31 | $0.13B | $0.10B | 76.15% |
| 2006-12-31 | $0.12B | $0.09B | 73.73% |
| 2006-09-30 | $0.11B | $0.06B | 49.56% |
| 2006-06-30 | $0.11B | $0.06B | 52.34% |
| 2006-03-31 | $0.10B | $0.03B | 30.10% |
| 2005-12-31 | $0.10B | $0.01B | 7.07% |
| 2005-09-30 | $0.09B | $0.01B | 7.53% |
| 2005-06-30 | $0.09B | $0.01B | 8.05% |
| 2005-03-31 | $0.08B | $0.01B | 7.14% |
| 2004-12-31 | $0.08B | $0.01B | 7.59% |
| 2004-09-30 | $0.07B | $0.01B | 9.72% |
| 2004-06-30 | $0.07B | $0.01B | 10.29% |
| 2004-03-31 | $0.07B | $0.01B | 12.31% |
| 2003-12-31 | $0.07B | $0.01B | 13.64% |
| 2003-09-30 | $0.07B | $0.02B | 31.82% |
| 2003-06-30 | $0.06B | $0.02B | 33.33% |
| 2003-03-31 | $0.06B | $0.02B | 36.21% |
| 2002-12-31 | $0.05B | $0.03B | 56.86% |
| 2002-09-30 | $0.05B | $0.02B | 52.17% |
| 2002-06-30 | $0.04B | $0.03B | 75.61% |
| 2001-12-31 | $0.04B | $0.04B | 100.00% |
| 2001-09-30 | $0.04B | $0.04B | 100.00% |
| 2001-06-30 | $0.03B | $0.03B | 100.00% |
| 2001-03-31 | $0.03B | $0.03B | 100.00% |
| 2000-12-31 | $0.03B | $0.03B | 83.33% |
| 2000-09-30 | $0.03B | $0.02B | 82.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.359B | 25.05 |
| EssilorLuxottica (ESLOY) | France | $151.069B | 0.00 |
| Boston Scientific (BSX) | United States | $138.964B | 31.78 |
| Stryker (SYK) | United States | $137.439B | 27.29 |
| Medtronic (MDT) | Ireland | $126.586B | 17.54 |
| Medline (MDLN) | United States | $57.028B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.992B | 0.00 |
| Agilent Technologies (A) | United States | $41.368B | 26.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.856B | 18.58 |
| ResMed (RMD) | United States | $37.873B | 26.21 |
| Koninklijke Philips (PHG) | Netherlands | $28.984B | 18.93 |
| Terumo (TRUMY) | Japan | $21.172B | 23.83 |
| Insulet (PODD) | United States | $19.900B | 61.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.686B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.986B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.585B | 30.87 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.350B | 13.25 |
| BillionToOne (BLLN) | United States | $4.319B | 0.00 |
| Envista Holdings (NVST) | United States | $3.979B | 22.83 |
| ICU Medical (ICUI) | United States | $3.666B | 23.28 |
| Haemonetics (HAE) | United States | $3.545B | 15.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.115B | 14.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.333B | 15.00 |
| Perrigo (PRGO) | Ireland | $2.045B | 5.12 |
| Neogen (NEOG) | United States | $2.043B | 44.71 |
| LeMaitre Vascular (LMAT) | United States | $1.939B | 39.02 |
| Curaleaf Holdings (CURLF) | Canada | $1.866B | 0.00 |
| AtriCure (ATRC) | United States | $1.858B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.734B | 76.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.302B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.170B | 347.00 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.112B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| Omeros (OMER) | United States | $0.927B | 0.00 |
| Valneva SE (VALN) | France | $0.893B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.03 |
| CeriBell (CBLL) | United States | $0.851B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.573B | 15.55 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.483B | 0.00 |
| Brainsway (BWAY) | Israel | $0.461B | 78.50 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Quanterix (QTRX) | United States | $0.343B | 0.00 |
| Evolus (EOLS) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 22.06 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.206B | 0.00 |
| Accendra Health (ACH) | United States | $0.200B | 2.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 16.64 |
| Quipt Home Medical (QIPT) | United States | $0.159B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| Exagen (XGN) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.76 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Nephros (NEPH) | United States | $0.047B | 33.92 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.74 |
| Jin Medical (ZJYL) | China | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |